Yanshan Huang
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma.
Journal: Annals of hematology
Published: October 28, 2024
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.
Journal: Signal transduction and targeted therapy
Published: August 28, 2024
γδ and αβ T-cell large granular lymphocytic leukaemia have similar characteristics and outcomes.
Journal: British journal of haematology
Published: August 16, 2024
Classification of NK-large granular lymphocytic leukemia by CD56 expression.
Journal: The oncologist
Published: July 15, 2024
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 15, 2023
Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes.
Journal: Haematologica
Published: April 27, 2023
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.
Journal: Frontiers in immunology
Published: March 11, 2023
Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemia.
Journal: Frontiers in immunology
Published: February 22, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026